Increase in cytokine production (IL-1β, IL-6, TNF-α but not IFN-γ, GM-CSF or LIF) by stimulated whole blood cells in postmenopausal osteoporosis

Maturitas

Volumn 26, Issue 1, 1997, Pages 63-71

  Zheng, S X ^a   Vrindts, Y ^a,b,c   Lopez, M ^a,b,c   De Groote, D ^a,b,c   Zangerle, P F ^a   Collette, J ^a   Franchimont, N ^a   Geenen, V ^a   Albert, A ^a   Reginster, J Y ^a,b,d  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c Medgenix Diagnostics SA   (Belgium)

^d UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

cytokines; densitometry; interleukin; menopause; osteoporosis

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BONE DENSITY; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; OSTEOPOROSIS; POSTMENOPAUSE;

BONE DENSITY; CLIMACTERIC; CYTOKINES; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; GROWTH INHIBITORS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; LYMPHOKINES; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; REFERENCE VALUES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031041978     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(96)01080-8     Document Type: Article

References (43)

1. Riggs BL, Melton LJ. Medical progress series: involutional osteoporosis. New Engl J Med 1986; 314: 1676-1686.
2. Horowitz MC. Cytokines and estrogen in bone: anti-osteoporotic effects. Science 1993; 260: 626-627.
3. Gowen M, Mundy GR. Actions of recombinant interleukin 1, interleukin 2, and interferon gamma on bone resorption in vitro. J Immunol 1986; 136: 2478-2482.
4. Roodman GD. Perspectives. Interleukin-6: an osteotropic factor? J Bone Miner Res 1992; 7: 475-477.
5. Jilka RL, Hangog G, Girasole G et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 1992; 257: 88-91.
6. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 1986; 319: 516-518.
7. Sisson SD, Dinarello CA. Production of interleukin-1α, interleukin-1β and tumor necrosis factor by human mononuclear cells stimulated with granulocyte-macrophage-colony-stimulating factor. Blood 1988; 72: 1368-1374.
8. Pacifici R, Avioli LV. The effects of natural and surgical menopause on the secretion of cytokines from human blood monocytes. Osteoporosis Int 1993; 3S1: 106-107.
9. Lorenzo JA, Souss SL, Fonseca JM, Hock JM, Medlock ES. Colony-stimulating factors regulate the development of multinucleated osteoclasts from recently replicated cells in vitro. J Clin Invest 1987; 80: 160-164.
10. Metcalf D, Gearing DP. Fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor. Proc Natl Acad Sci USA 1989; 86: 5948-5952.
11. Van Beek E, Van Der Wee-Pals L, Van De Ruit M, Nijweide P, Papapoulos S, Lowik C. Leukemia inhibitory factor inhibits osteoclastic resorption, growth, mineralization, and alkaline phosphatase activity in fetal mouse metacarpal bones in culture. J Bone Miner Res 1993; 8: 191-198.
12. Pacifici R, Rifas L, McCracken R, Vered I, McMurty C, Avioli LV, Peck WA. Ovarian steroid treatment blocks a postmenopausal increase in blood monocytes interleukin-1 release. Proc Natl Acad Sci USA 1989; 86: 2398-2402.
13. Pacifici R, Brown C, Puscheck E et al. Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci USA 1991; 88: 5134-5138.
14. Kimble RB, Vannice JL, Bloedow DC et al. Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats. J Clin Invest 1994; 93: 1959-1967.
15. McKane WR, Khosla S, Peterson JM, Egan K, Riggs BL. Circulating levels of cytokines that modulate bone resorption: effects of age and menopause in women. J Bone Miner Res 1994; 9: 1313-1318.
16. Ralston SH. Analysis of gene expression in human bone biopsies by polymerase chain reaction: evidence for enhanced cytokine expression in postmenopausal osteoporosis. J Bone Miner Res 1994; 9: 883-890.
17. Hustmyer FG, Walker E, Yu XP, Girasole G, Sakagami Y, Peacock M, Manolagas S. Cytokine production and surface antigen expression by peripheral blood mononuclear cells in postmenopausal osteoporosis. J Bone Miner Res 1993; 9: 51-59.
18. Khosla S, Peterson JM, Egan K, Jones JD, Riggs BL. Circulating cytokine levels in osteoporotic and normal women. J Clin Endocrinol Metab 1994; 79: 707-711.
19. De Groote D, Zangerle PF, Gevaert Y et al. Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IL-2, IFN-γ and GM-CSF) in whole blood. Comparisons with isolated PBMC stimulation. Cytokine 1992; 4: 239-248.
20. Krolner B, Porsnielsen S. Measurement of bone mineral content (BMC) of the lumbar spine. Theory and application of a new time-dimensional dual photon attenuation method. Scand J Clin Lab Invest 1980; 40: 653-663.
21. Reginster JY, Geusens P, Nijs J, Denis D, Franchimont P, Dequeker J. In vivo long term precision of spinal bone mass measurement by dual photon absorptiometry. Bone Miner 1989; 6: 225-229.
22. WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. World Health Organization Technical Report Series 843, World Health Organization, Geneva, ISBN 1994; 92-4-120843-0, 129 pp.
23. Reginster JY, Denis D, Deroisy R, Albert A, Sarlet N, Collette J, Franchimont P. Dual photon absorptiometry of lumbar spine in Western European (Belgian) postmenopausal females: normal range and fracture threshold. Clin Rheumatol 1990; 9: 220-224.
24. Riggs BL, Wahner HW, Dunn WL, Mazess RB, Oxford KP, Melton LJ. Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. J Clin Invest 1981; 67: 328-335.
25. Zangerle PF, De Groote D, Lopez M et al. Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IL-2, IFN-γ and GM-CSF) in whole blood. Application to rheumatoid arthritis and osteoarthritis. Cytokine 1992; 4: 568-575.
26. Pacifici R, Rifas L, Teitelbaum S et al. Spontaneous release of interleukin-1 from human blood monocytes reflects bone formation in idiopathic osteoporosis. Proc Natl Acad Sci USA 1987; 84: 4616-4620.
27. Pacifici R, Vannice JL, Rifas L, Kimble RB. Monocytic secretion of interleukin-1 receptor antagonist in normal and osteoporotic women: effects of menopause and estrogen/progesterone therapy. J Clin Endocrinol Metab 1993; 77: 1135-1141.
28. Pacifici R, Carano A, Santoro SA et al. Bone matrix constituents stimulate interleukin-1 release from human blood mononuclear cells. J Clin Invest 1991; 87: 221-228.
29. Wong GG, Witek JAS, Temple PA, Kritz R, Ferenz C, Hewick RM. Stimulation of murine hematopoietic colony formation by human interleukin-6. J Immunol 1988; 140: 3040-3044.
30. Hattersley G, Kerby JA, Chambers T. Identification of osteoclast precursors in multilineage hematopoietic colonies. Endocrinology 1991; 128: 259-262.
31. Kurihara N, Civin C, Roodman GD. Osteoporotic factor responsiveness of highly purified populations of early and late precursors for human multinucleated cells expressing the osteoclast phenotype. J Bone Miner Res 1991; 6: 257-261.
32. Girasole G, Jilka RL, Passeri G, Boswell S, Boder G, Williams DC, Boyde A, Suda T. 17β-Estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro. A potential mechanism for the anti-osteoporotic effects of estrogen. J Clin Invest 1992; 89: 883-891.
33. Kassem M, Harris SA, Spelsberg TC, Riggs BL. Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line with high levels of estrogen receptors. J Bone Miner Res 1996; 11: 193-199.
34. Pottratz ST, Bellido T, Mocharia H, Crabb D, Manolagas SC. 17β-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism. J Clin Invest 1994; 93: 944-950.
35. Ray A, Prefontaine KE, Ray P. Down-modulation of interleukin-6 gene expression by 17β-estradiol in the absence of high affinity DNA binding by the estrogen receptor. J Biol Chem 1994; 269: 12940-12946.
36. Stein B, Yang MX. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-κB and C/EBPβ. Mol Cell Biol 1995; 15: 4971-4979.
37. Manolagas SV, Jilka RL, Girasole G, Passeri G, Bellido T. Estrogen, cytokines, and the control of osteoclast formation and bone resorption in vivo and in vitro. Osteoporosis Int 1993; 3S1: S114-S116.
38. Rickard D, Russell G, Gowen M. Oestradiol inhibits the release of tumour necrosis factor but not interleukin-6 from adult human osteoblasts in vitro. Osteoporosis Int 1992; 2: 94-102.
39. Rifas L, Kenney JS, Marcelli M, Pacifia R, Cheng SL, Dawson L, Avioli LV. Production of interleukin-6 in human osteoblasts and human bone marrow stromal cells: evidence that induction by interleukin-1 and tumor necrosis factor-a is not regulated by ovarian steroids. Endocrinology 1995; 136: 4056-4067.
40. Cohen-Solal ME, Graulet AM, Gueris J, Denne MA, Bergot C, Morieux C, Sedel L, Kuntz D, De Vernejoul MC. Bone resorption at the femoral neck is dependent on local factors in nonosteoporotic late postmenopausal women: an in vitro-in vivo study. J Bone Miner Res 1995; 10: 307-314.
41. Prince R, Dick I, Devine A et al. Importance of bone resorption in the determination of bone density in women more than 10 years past the menopause. J Bone Miner Res 1993; 8: 1273-1279.
42. Zarrabeita MT, Riancho JA, Amado JA, Napal J, Gonzalez-Macias J. Cytokine production by peripheral blood cells in postmenopausal osteoporosis. Bone Miner 1991; 14: 161-167.
43. Haraoui B, Wilder RL, Malone DG, Allen JB, Katona IM, Wahl SM. Immune function in severe, active rheumatoid arthritis: a relationship between peripheral blood mononuclear cell proliferation to soluble antigens and mononuclear cell subset profiles. J Immunol 1984; 133: 697-701.